American Well Corporation

NYSE AMWL

American Well Corporation Revenue for the Trailing 12 Months (TTM) ending September 30, 2024: USD 254.03 M

American Well Corporation Revenue is USD 254.03 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -5.07% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • American Well Corporation Revenue for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 267.60 M, a -1.15% change year over year.
  • American Well Corporation Revenue for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 270.71 M, a 12.57% change year over year.
  • American Well Corporation Revenue for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 240.47 M, a 4.61% change year over year.
  • American Well Corporation Revenue for the Trailing 12 Months (TTM) ending September 30, 2020 was USD 229.87 M.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
SV Wall Street
NYSE: AMWL

American Well Corporation

CEO Dr. Ido Schoenberg M.D.
IPO Date Sept. 17, 2020
Location United States
Headquarters 75 State Street
Employees 1,104
Sector Health Care
Industries
Description

American Well Corporation operates as a telehealth software company that enables digital delivery of care for healthcare. The company products offer urgent care; scheduled visits; acute behavioral health; telestroke; pediatrics; retail health, school health, and home settings. Its application offers urgent care; pediatrics; therapy; menopause nutrition; end-stage renal disease and dialysis; dermatology care; behavioral health therapy; and musculoskeletal care. The company also provides telemedicine equipment, including telemedicine carts, peripherals, tyto care, TV kits, tablets, and kiosks. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Similar companies

PRVA

Privia Health Group, Inc.

USD 22.73

-0.61%

TDOC

Teladoc Health, Inc.

USD 10.52

3.04%

PGNY

Progyny, Inc.

USD 23.59

2.79%

DH

Definitive Healthcare Corp.

USD 5.01

8.44%

CERT

Certara, Inc.

USD 13.87

3.51%

PHR

Phreesia, Inc.

USD 29.29

8.56%

GDRX

GoodRx Holdings, Inc.

USD 4.89

0.83%

HCAT

Health Catalyst, Inc.

USD 5.79

1.94%

SDGR

Schrödinger, Inc.

USD 25.52

6.02%

GEHC

GE HealthCare Technologies Inc.

USD 87.78

-1.36%

VEEV

Veeva Systems Inc.

USD 232.24

2.87%

TXG

10x Genomics, Inc.

USD 14.84

-0.07%

DOCS

Doximity, Inc.

USD 57.13

3.22%

StockViz Staff

January 30, 2025

Any question? Send us an email